DrugPatentWatch Database Preview

Details for Patent: 9,700,530

« Back to Dashboard

Which drugs does patent 9,700,530 protect, and when does it expire?

Patent 9,700,530 protects KAPSPARGO SPRINKLE and is included in one NDA.

This patent has eight patent family members in seven countries.

Summary for Patent: 9,700,530

Title:	Capsule dosage form of metoprolol succinate
Abstract:	This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed Toprol-XL.RTM. tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.
Inventor(s):	Vats; Sandeep Kumar (Sonipat, IN), Mondal; Balaram (East Midnapore, IN), Ramaraju; Kalaiselvan (Tiruchirappalli, IN), Singh; Romi Barat (Benares, IN)
Assignee:	SUN PHARMACEUTICAL INDUSTRIES LIMITED (Mumbai, IN)
Application Number:	15/337,611
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 9,700,530

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Spil	KAPSPARGO SPRINKLE	metoprolol succinate	CAPSULE, EXTENDED RELEASE;ORAL	210428-001	Jan 26, 2018		RX	Yes	No			Y
Spil	KAPSPARGO SPRINKLE	metoprolol succinate	CAPSULE, EXTENDED RELEASE;ORAL	210428-002	Jan 26, 2018		RX	Yes	No			Y
Spil	KAPSPARGO SPRINKLE	metoprolol succinate	CAPSULE, EXTENDED RELEASE;ORAL	210428-003	Jan 26, 2018		RX	Yes	No			Y

International Family Members for US Patent 9,700,530

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015287299
Brazil	112017000468
Canada	2954474